29 Programs

  • Perspectives on New Datasets in FLT3- and IDH1/2-Mutant Acute Myeloid Leukemia

    Explore program
  • Optimizing the Management of Endocrine-Resistant HR-Positive Metastatic Breast Cancer

    Explore program
  • Current and Future Role of Menin Inhibitors for Patients with Acute Myeloid Leukemia

    Explore program
  • Current and Future Management of IDH-Mutant Low-Grade Glioma

    Explore program